2m 2m 2m 2m 2m 2m 2m
OVID THERAPTCS (OVID)
NASDAQ
$2.40-$0.03 (-1.40%)
Price as of Jul 14, 2026 4:09 AM EDT- $453.5MMarket Cap
- 512.24%1-Year Change
- BiotechnologyIndustry
OVID THERAPTCS (OVID)
$2.40-$0.03 (-1.40%)
OVID | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.43 | ||
Change | -$0.09 (-3.57%) | ||
Open | $2.45 | ||
High | $2.49 | ||
Low | $2.39 | ||
Previous Close | $2.52 | ||
Volume | 1,147,843 | ||
30-Day Average Volume | 3,980,120 | ||
1-Week Change | -6.90% | ||
1-Month Change | 5.65% | ||
1-Year Change | 512.24% | ||
3-Year Change | -28.74% | ||
5-Year Change | -36.55% | ||
Fundamentals | |||
Shares Outstanding | 186.6M | ||
Total Assets | $225.6M | ||
Market Cap | $453.5M | ||
Enterprise Value | $359.5M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$17.0M | ||
Free Cash Flow | -$13.9M | ||
EBIT | -$17.0M | ||
EBITDA | -$17.0M | ||
Net Working Capital | $144.4M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue